Cargando…
Effect of gemigliptin on cardiac ischemia/reperfusion and spontaneous hypertensive rat models
Diabetes is associated with an increased risk of cardiovascular complications. Dipeptidyl peptidase-4 (DPP-IV) inhibitors are used clinically to reduce high blood glucose levels as an antidiabetic agent. However, the effect of the DPP-IV inhibitor gemigliptin on ischemia/reperfusion (I/R)-induced my...
Autores principales: | Nam, Dae-Hwan, Park, Jinsook, Park, Sun-Hyun, Kim, Ki-Suk, Baek, Eun Bok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717789/ https://www.ncbi.nlm.nih.gov/pubmed/31496870 http://dx.doi.org/10.4196/kjpp.2019.23.5.329 |
Ejemplares similares
-
Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
por: Kim, Hae Jin, et al.
Publicado: (2018) -
Gemigliptin Alleviates Succinate-Induced Hepatic Stellate Cell Activation by Ameliorating Mitochondrial Dysfunction
por: Nguyen, Giang, et al.
Publicado: (2022) -
Protective Effects of Galium verum L. Extract against Cardiac Ischemia/Reperfusion Injury in Spontaneously Hypertensive Rats
por: Bradic, Jovana, et al.
Publicado: (2019) -
Endoplasmic reticulum stress response in spontaneously hypertensive rats is affected by myocardial ischemia reperfusion injury
por: GUO, XIAO-FU, et al.
Publicado: (2015) -
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
por: Seo, Jung Beom, et al.
Publicado: (2019)